Over the previous few years, there was a gradual inflow of startups attempting to deal with points like despair, interval ache, PMS, nervousness and insomnia through the use of wearables that apply electrical, magnetic or ultrasonic indicators to stimulate the mind.
San Francisco-based Mave Health is the most recent of that fleet, and claims its $495, neuromodulation headset can enhance consideration and temper, regulate stress, and even measure psychological well being. The startup is positioning the wearable as a non-medical system so it received’t want clearance from businesses just like the U.S. Meals and Drug Administration (FDA) to promote within the U.S.
Dhawal Jain, who began the corporate in 2023 together with his faculty batch mates Jai Sharma (CMO) and Aman Kumar (CTO), mentioned he realized the necessity for such a tool after his flatmate’s fiancée dedicated suicide in the course of the COVID-19 pandemic lockdowns.
“In India, committing suicide is against the law, which meant there was police concerned, and we needed to communicate to her psychologist. The solutions we bought from them made us query if any of it made sense. We began connecting with different psychologists and had been getting the identical solutions,” Jain mentioned.
The founders felt that there was no tangible method to measure progress within the psychological well being house. “For instance, when you ask a psychologist how have you learnt if an individual is making progress, their response to it is rather commonplace, which is that it’s not about progress. It’s about course of […] However for someone with despair who’s spending loads of time in remedy, progress is essential. So how have you learnt whether or not they’re making progress or not? And even these primary questions weren’t being answered.”
In an effort to resolve that, the workforce began to be taught extra about neuroscience by speaking to consultants, and shortly after realized that whereas there was progress round neuromodulation in labs, customers haven’t had the good thing about it.
The corporate then labored with medical system and psychological well being consultants to conduct trials of the expertise. However finally it took a unique route and positioned its headset as a life-style system. Jain mentioned this strategy would let Mave attain a wider viewers.
Techcrunch occasion
San Francisco, CA
|
October 13-15, 2026
The system and expertise
Mave Well being’s system employs transcranial direct present stimulation (tDCS), a non-invasive approach to manage low-intensity currents to the mind to fireplace up neurons. The approach is typically utilized in psychology, and is claimed to be secure. Unintended effects are gentle and short-term, like itching or discomfort.
The headset delivers a low 1-2 mA present to stimulate the mind. The startup says prospects can use the system, which weighs roughly 100 grams, anytime, and recommends every day classes spanning 20 minutes for the primary few weeks of utilization.
The startup additionally gives an app that may measure long-term developments in temper, focus and stress ranges. It may additionally combine with different well being knowledge and monitor measures like Coronary heart Charge Variability (HRV). Jain mentioned customers begin with a self-reported baseline evaluation once they begin, and full follow-up assessments each two to 4 weeks, which helps Mave perceive if the system helps a person in the long run.

The corporate hasn’t carried out any scientific trials or revealed any research but. Nevertheless, Jain says it labored with greater than 500 customers in a personal beta in 2024 and 2025, throughout which eight in ten customers reported a 60% enhance in productiveness. The startup famous that 75% of its personal beta customers additionally reported a discount in stress from their baseline inside two months of utilization.
Mave Well being mentioned it has carried out 4 observational research throughout 200 individuals which might be underneath tutorial evaluation with an intention to publish this yr.
Dr. Himanshu Nirvan, a Delhi-based psychiatrist who labored with Mave Well being as a advisor, mentioned that tDCS-based units are thought of a confirmed method to tackle psychological health-related points. Nevertheless, he famous that he hasn’t regarded on the expertise from a life-style lens.
The corporate says it ran a program in India with Dr. Nirvan to check the system and the expertise.
“We did choose loads of sufferers, and it was basically a great program for my part. Issues like which might be usually not very ceaselessly and simply out there even within the psychological well being administration house,” Dr. Nirvan mentioned. “I felt that for lots of people, tDCS is definitely fairly a great modality, contemplating that it’s a really moveable system. You possibly can basically cost it at house, take it wherever you need, even when you’re touring.”
Leigh Elkin Charvet, a scientific neuropsychologist and Professor of Neurology at NYU Grossman College of Drugs, instructed TechCrunch over electronic mail that whereas tDCS is taken into account a secure and efficient strategy to neuromodulation, units must be designed effectively to align electrodes correctly, and customers have to have common and constant classes.
“One problem is that buyers could use the system with out scientific screening or clear steering about whether or not it’s acceptable for his or her signs. One other is that it may be troublesome for customers to find out whether or not the system is definitely serving to if outcomes should not being measured in a structured manner,” she mentioned.
Charvet added that using tDCS for broad way of life enhancement in wholesome people has not been studied broadly. “Thus far, many of the strongest analysis has centered on scientific populations or structured cognitive coaching paradigms. We don’t but have clear steering or sturdy proof supporting using tDCS to enhance efficiency in in any other case wholesome people. A way of life use case should still emerge, however that may depend on clearly defining goal outcomes and demonstrating that results are measurable and reproducible,” she mentioned.
The system is at present out there for pre-order, and the corporate is aiming to ship its first batch to prospects within the U.S. and India in April 2026.
The corporate just lately raised $2.1 million in a seed funding spherical led by Blume Ventures, with participation from particular person traders who embody Tesla Autopilot AI lead Dhaval Shroff. The startup has raised just below $3 million in funding so far.
Thanks for studying! Be part of our neighborhood at Spectator Daily

















